Fruebjergvej 3
Copenhagen 2100
Denmark
45 22 11 53 99
https://www.2curex.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Ole Thastrup VD | Co-Founder & Vice Chairman | 150k | N/A | 1953 |
Mr. Kenneth Graabek Johansen | Acting CEO & CFO | N/A | N/A | 1976 |
Ms. Grith Hagel | Co-Founder, VP of Innovation & Director | N/A | N/A | 1959 |
Mr. Jacob Thastrup | Chief Technology Officer | N/A | N/A | 1979 |
Mr. Manuel Fernandez | Director Quality & Regulatory Affairs | N/A | N/A | N/A |
2cureX AB (publ) operates as a medtech company in Europe. The company's principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.
2cureX AB (publ)s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.